Breaking News Instant updates and real-time market news.

FTEK

Fuel Tech

$1.90 /

+0.01 (+0.53%)

16:20
07/26/21
07/26
16:20
07/26/21
16:20

Fuel Tech awarded air pollution control orders for $4.5M

Fuel Tech announced the receipt of multiple air pollution control contracts from customers in Korea, North America, and Europe. These awards have an aggregate value of approximately $4.5M.

TODAY'S FREE FLY STORIES

General news
European stock markets rebounded as risk appetite stabilised. » 06:40
09/21/21
09/21
06:40
09/21/21
06:40
$ECON

Economic Data

/

+

European stock markets…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
Sage Therapeutics appoints Chris Benecchi as Chief Commercial Officer » 06:39
09/21/21
09/21
06:39
09/21/21
06:39
SAGE

Sage Therapeutics

$45.25 /

-1.07 (-2.31%)

Sage Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SAGE Sage Therapeutics
$45.25 /

-1.07 (-2.31%)

SAGE Sage Therapeutics
$45.25 /

-1.07 (-2.31%)

08/04/21 RBC Capital
Sage Therapeutics price target lowered to $55 from $60 at RBC Capital
08/04/21 H.C. Wainwright
Sage Therapeutics price target lowered to $80 from $86 at H.C. Wainwright
07/27/21 Canaccord
Sage Therapeutics price target lowered to $96 from $119 at Canaccord
06/24/21 Piper Sandler
Piper Sandler sees 'asymmetric' risk reward for Sage Therapeutics investors
SAGE Sage Therapeutics
$45.25 /

-1.07 (-2.31%)

SAGE Sage Therapeutics
$45.25 /

-1.07 (-2.31%)

Recommendations
Entergy price target lowered to $114 from $127 at Mizuho » 06:39
09/21/21
09/21
06:39
09/21/21
06:39
ETR

Entergy

$109.50 /

-1.54 (-1.39%)

Mizuho analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ETR Entergy
$109.50 /

-1.54 (-1.39%)

ETR Entergy
$109.50 /

-1.54 (-1.39%)

08/23/21 Mizuho
Entergy price target raised to $127 from $120 at Mizuho
08/17/21 Wells Fargo
Entergy price target raised to $125 from $120 at Wells Fargo
08/17/21 Wells Fargo
Entergy price target raised to $125 from $120 at Wells Fargo
08/05/21 Citi
Entergy price target raised to $110 from $101 at Citi
ETR Entergy
$109.50 /

-1.54 (-1.39%)

ETR Entergy
$109.50 /

-1.54 (-1.39%)

Upgrade
South State upgraded to Buy from Neutral at DA Davidson » 06:39
09/21/21
09/21
06:39
09/21/21
06:39
SSB

South State

$63.76 /

-1.01 (-1.56%)

DA Davidson analyst Kevin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SSB South State
$63.76 /

-1.01 (-1.56%)

SSB South State
$63.76 /

-1.01 (-1.56%)

08/16/21
Fly Intel: Top five analyst downgrades
08/16/21 Stephens
South State downgraded to Equal Weight from Overweight at Stephens
07/27/21 Truist
South State price target lowered to $90 from $100 at Truist
07/27/21 Piper Sandler
Atlantic Capital downgraded to Neutral from Overweight at Piper Sandler
SSB South State
$63.76 /

-1.01 (-1.56%)

Recommendations
MSCI price target raised to $720 from $650 at RBC Capital » 06:38
09/21/21
09/21
06:38
09/21/21
06:38
MSCI

MSCI

$634.57 /

-7.14 (-1.11%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSCI MSCI
$634.57 /

-7.14 (-1.11%)

MSCI MSCI
$634.57 /

-7.14 (-1.11%)

08/03/21 Deutsche Bank
MSCI price target raised to $650 from $600 at Deutsche Bank
07/28/21 Oppenheimer
MSCI price target raised to $626 from $566 at Oppenheimer
07/28/21 Deutsche Bank
MSCI price target raised to $600 from $525 at Deutsche Bank
07/28/21 Barclays
MSCI price target raised to $700 from $545 at Barclays
MSCI MSCI
$634.57 /

-7.14 (-1.11%)

Hot Stocks
Johnson & Johnson announces new data on COVID-19 vaccine » 06:37
09/21/21
09/21
06:37
09/21/21
06:37
JNJ

Johnson & Johnson

$163.79 /

-1.01 (-0.61%)

Johnson & Johnson…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$163.79 /

-1.01 (-0.61%)

JNJ Johnson & Johnson
$163.79 /

-1.01 (-0.61%)

09/16/21 Jefferies
Genmab downgraded to Hold from Buy at Jefferies
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley downgrades J&J to Equal Weight amid limited mid-term newsflow
JNJ Johnson & Johnson
$163.79 /

-1.01 (-0.61%)

JNJ Johnson & Johnson
$163.79 /

-1.01 (-0.61%)

JNJ Johnson & Johnson
$163.79 /

-1.01 (-0.61%)

JNJ Johnson & Johnson
$163.79 /

-1.01 (-0.61%)

Earnings
Americold Realty Trust cuts FY21 AFFO view to 1.15-$1.20 from $1.34-$1.40 » 06:37
09/21/21
09/21
06:37
09/21/21
06:37
COLD

Americold Realty Trust

$34.50 /

-0.155 (-0.45%)

FY21 consensus $1.34.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COLD Americold Realty Trust
$34.50 /

-0.155 (-0.45%)

COLD Americold Realty Trust
$34.50 /

-0.155 (-0.45%)

09/01/21 Barclays
Americold Realty Trust initiated with an Underweight at Barclays
08/25/21 Baird
Americold Realty Trust price target lowered to $42 from $45 at Baird
08/20/21 Truist
Americold Realty Trust price target lowered to $42 from $44 at Truist
08/09/21 Citi
Americold Realty Trust downgraded to Neutral following earnings miss at Citi
COLD Americold Realty Trust
$34.50 /

-0.155 (-0.45%)

  • 14
    Oct
Hot Stocks
FDA clears Oric Pharma's IND for ORIC-533 » 06:36
09/21/21
09/21
06:36
09/21/21
06:36
ORIC

Oric Pharmaceuticals

$24.54 /

-0.67 (-2.66%)

ORIC Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ORIC Oric Pharmaceuticals
$24.54 /

-0.67 (-2.66%)

ORIC Oric Pharmaceuticals
$24.54 /

-0.67 (-2.66%)

07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy after tumor data at Citi
07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy from Neutral at Citi
03/25/21 H.C. Wainwright
Oric Pharmaceuticals price target raised to $54 from $52 at H.C. Wainwright
01/25/21 Citi
Oric Pharmaceuticals downgraded to Neutral from Buy at Citi
ORIC Oric Pharmaceuticals
$24.54 /

-0.67 (-2.66%)

  • 13
    Nov
ORIC Oric Pharmaceuticals
$24.54 /

-0.67 (-2.66%)

Recommendations
Citi survey shows Nike 'back in favor' with Chinese consumer » 06:35
09/21/21
09/21
06:35
09/21/21
06:35
NKE

Nike

$154.23 /

-2.25 (-1.44%)

Citi analyst Paul Lejuez…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NKE Nike
$154.23 /

-2.25 (-1.44%)

NKE Nike
$154.23 /

-2.25 (-1.44%)

09/20/21 Deutsche Bank
Nike price target lowered to $171 from $179 at Deutsche Bank
09/20/21 Piper Sandler
Nike supply chain disruptions creates buying opportunity, says Piper Sandler
09/13/21
Fly Intel: Top five analyst downgrades
09/13/21 BTIG
BTIG downgrades Nike on 'severe supply chain disruptions' in Vietnam
NKE Nike
$154.23 /

-2.25 (-1.44%)

NKE Nike
$154.23 /

-2.25 (-1.44%)

NKE Nike
$154.23 /

-2.25 (-1.44%)

NKE Nike
$154.23 /

-2.25 (-1.44%)

Recommendations
Axalta Coating price target lowered to $36 from $38 at RBC Capital » 06:34
09/21/21
09/21
06:34
09/21/21
06:34
AXTA

Axalta Coating

$27.96 /

-0.61 (-2.14%)

RBC Capital analyst Arun…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AXTA Axalta Coating
$27.96 /

-0.61 (-2.14%)

AXTA Axalta Coating
$27.96 /

-0.61 (-2.14%)

09/15/21 BofA
Axalta Coating removed from US 1 List at BofA
09/09/21 Citi
Axalta Coating downgraded to Neutral from Buy at Citi
09/09/21 Citi
Axalta Coating downgraded to Neutral from Buy at Citi
07/28/21 Deutsche Bank
Axalta Coating price target lowered to $36 from $38 at Deutsche Bank
AXTA Axalta Coating
$27.96 /

-0.61 (-2.14%)

AXTA Axalta Coating
$27.96 /

-0.61 (-2.14%)

AXTA Axalta Coating
$27.96 /

-0.61 (-2.14%)

Hot Stocks
Aerie Pharmaceuticals says Vicente Anido, PhD no longer serving as CEO » 06:34
09/21/21
09/21
06:34
09/21/21
06:34
AERI

Aerie Pharmaceuticals

$11.59 /

-1.27 (-9.88%)

Aerie Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AERI Aerie Pharmaceuticals
$11.59 /

-1.27 (-9.88%)

AERI Aerie Pharmaceuticals
$11.59 /

-1.27 (-9.88%)

11/09/20 H.C. Wainwright
Aerie Pharmaceuticals price target lowered to $29 from $31 at H.C. Wainwright
10/28/20 H.C. Wainwright
Aerie Pharmaceuticals $50M upfront should reduce overhang, says H.C. Wainwright
10/19/20 BofA
Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA
10/19/20 BofA
Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA
AERI Aerie Pharmaceuticals
$11.59 /

-1.27 (-9.88%)

AERI Aerie Pharmaceuticals
$11.59 /

-1.27 (-9.88%)

Initiation
Citi Trends initiated with a Buy at Benchmark » 06:34
09/21/21
09/21
06:34
09/21/21
06:34
CTRN

Citi Trends

$70.61 /

+0.5 (+0.71%)

Benchmark analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTRN Citi Trends
$70.61 /

+0.5 (+0.71%)

CTRN Citi Trends
$70.61 /

+0.5 (+0.71%)

08/25/21 Craig-Hallum
Citi Trends price target raised to $165 from $150 at Craig-Hallum
05/26/21 Craig-Hallum
Citi Trends price target raised to $150 from $142 at Craig-Hallum
04/15/21 Craig-Hallum
Citi Trends price target raised to $142 from $125 at Craig-Hallum
03/17/21 Craig-Hallum
Citi Trends price target raised to $125 from $93 at Craig-Hallum
CTRN Citi Trends
$70.61 /

+0.5 (+0.71%)

Earnings
Apogee Enterprises sees FY22 adjusted EPS $2.20-$2.40, consensus $2.28 » 06:34
09/21/21
09/21
06:34
09/21/21
06:34
APOG

Apogee Enterprises

$39.34 /

-1.09 (-2.70%)

The company previously…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APOG Apogee Enterprises
$39.34 /

-1.09 (-2.70%)

APOG Apogee Enterprises
$39.34 /

-1.09 (-2.70%)

06/28/21 Craig-Hallum
Apogee Enterprises price target raised to $48 from $43 at Craig-Hallum
04/09/21 DA Davidson
Apogee Enterprises price target raised to $33 from $28 at DA Davidson
12/21/20 Craig-Hallum
Apogee Enterprises price target raised to $39 from $31 at Craig-Hallum
APOG Apogee Enterprises
$39.34 /

-1.09 (-2.70%)

APOG Apogee Enterprises
$39.34 /

-1.09 (-2.70%)

Hot Stocks
Activision Blizzard says working with regulators to address workplace complaints » 06:33
09/21/21
09/21
06:33
09/21/21
06:33
ATVI

Activision Blizzard

$76.20 /

-3.415 (-4.29%)

, DIS

Disney

$178.63 /

-4.865 (-2.65%)

Activision Blizzard…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATVI Activision Blizzard
$76.20 /

-3.415 (-4.29%)

DIS Disney
$178.63 /

-4.865 (-2.65%)

ATVI Activision Blizzard
$76.20 /

-3.415 (-4.29%)

09/15/21 KeyBanc
EA's delay of Battlefield 2042 slight positive for Activision, says KeyBanc
09/15/21 Benchmark
EA shares reacting negatively to Battlefield 2042 delay rumors, says Benchmark
09/15/21 Truist
Battlefield 2042 delay would be 'modest negative' for EA, says Truist
09/13/21 JPMorgan
Activision should be bought on China regulation concerns, says JPMorgan
DIS Disney
$178.63 /

-4.865 (-2.65%)

05:19 Today Daiwa
Disney initiated with a Buy at Daiwa
09/13/21 Stephens
Recent Apple TV+ news positive for Roku, says Stephens
09/10/21 Truist
Apple will likely appeal ruling in Epic case, says Truist
09/09/21 Arete
Disney initiated with a Buy at Arete
ATVI Activision Blizzard
$76.20 /

-3.415 (-4.29%)

DIS Disney
$178.63 /

-4.865 (-2.65%)

ATVI Activision Blizzard
$76.20 /

-3.415 (-4.29%)

DIS Disney
$178.63 /

-4.865 (-2.65%)

ATVI Activision Blizzard
$76.20 /

-3.415 (-4.29%)

DIS Disney
$178.63 /

-4.865 (-2.65%)

ATVI Activision Blizzard
$76.20 /

-3.415 (-4.29%)

DIS Disney
$178.63 /

-4.865 (-2.65%)

Hot Stocks
Verso enters confidentiality agreement with Atlas Holdings » 06:32
09/21/21
09/21
06:32
09/21/21
06:32
VRS

Verso

$19.38 /

-0.13 (-0.67%)

Verso announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRS Verso
$19.38 /

-0.13 (-0.67%)

VRS Verso
$19.38 /

-0.13 (-0.67%)

08/09/21 B. Riley
Verso downgraded to Neutral on valuation at B. Riley
08/09/21 B. Riley
Verso downgraded to Neutral from Buy at B. Riley
07/13/21 BWS Financial
Atlas proposal 'materially undervalues' Verso, says BWS Financial
05/10/21 BWS Financial
Verso price target raised to $30 from $25.50 at BWS Financial
Earnings
Apogee Enterprises reports Q2 adjusted EPS 53c, consensus 55c » 06:31
09/21/21
09/21
06:31
09/21/21
06:31
APOG

Apogee Enterprises

$39.34 /

-1.09 (-2.70%)

Reports Q2 revenue $326M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APOG Apogee Enterprises
$39.34 /

-1.09 (-2.70%)

APOG Apogee Enterprises
$39.34 /

-1.09 (-2.70%)

06/28/21 Craig-Hallum
Apogee Enterprises price target raised to $48 from $43 at Craig-Hallum
04/09/21 DA Davidson
Apogee Enterprises price target raised to $33 from $28 at DA Davidson
12/21/20 Craig-Hallum
Apogee Enterprises price target raised to $39 from $31 at Craig-Hallum
APOG Apogee Enterprises
$39.34 /

-1.09 (-2.70%)

APOG Apogee Enterprises
$39.34 /

-1.09 (-2.70%)

Upgrade
Jefferies upgrades Steven Madden to Buy on 'best-in-class' supply chain » 06:30
09/21/21
09/21
06:30
09/21/21
06:30
SHOO

Steven Madden

$39.18 /

-0.49 (-1.24%)

Jefferies analyst Janine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SHOO Steven Madden
$39.18 /

-0.49 (-1.24%)

SHOO Steven Madden
$39.18 /

-0.49 (-1.24%)

04:43 Today Jefferies
Steven Madden upgraded to Buy from Hold at Jefferies
09/17/21 BTIG
Steven Madden price target raised to $59 from $57 at BTIG
07/29/21 B. Riley
Steven Madden price target raised to $51 from $50 at B. Riley
07/29/21 Piper Sandler
Steven Madden price target raised to $45 from $39 at Piper Sandler
SHOO Steven Madden
$39.18 /

-0.49 (-1.24%)

Downgrade
Zumiez downgraded to Hold on slowing skate cycle at Jefferies » 06:27
09/21/21
09/21
06:27
09/21/21
06:27
ZUMZ

Zumiez

$40.89 /

-1.75 (-4.10%)

Jefferies analyst Janine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZUMZ Zumiez
$40.89 /

-1.75 (-4.10%)

ZUMZ Zumiez
$40.89 /

-1.75 (-4.10%)

04:44 Today Jefferies
Zumiez downgraded to Hold from Buy at Jefferies
09/13/21 B. Riley
Zumiez price target lowered to $56 from $65 at B. Riley
09/10/21 Baird
Zumiez price target lowered to $47 from $52 at Baird
09/08/21 Pivotal Research
Zumiez price target lowered to $45 from $52 at Pivotal Research
ZUMZ Zumiez
$40.89 /

-1.75 (-4.10%)

ZUMZ Zumiez
$40.89 /

-1.75 (-4.10%)

Initiation
Univar initiated with a Buy at UBS » 06:24
09/21/21
09/21
06:24
09/21/21
06:24
UNVR

Univar

$22.07 /

-0.42 (-1.87%)

UBS analyst Joshua…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UNVR Univar
$22.07 /

-0.42 (-1.87%)

UNVR Univar
$22.07 /

-0.42 (-1.87%)

08/25/21
Fly Intel: Top five analyst upgrades
08/25/21 Berenberg
Univar upgraded to Buy from Hold at Berenberg
05/11/21 Wells Fargo
Univar price target raised to $27 from $19 at Wells Fargo
05/11/21 Barclays
Univar price target raised to $28 from $22 at Barclays
UNVR Univar
$22.07 /

-0.42 (-1.87%)

UNVR Univar
$22.07 /

-0.42 (-1.87%)

UNVR Univar
$22.07 /

-0.42 (-1.87%)

Initiation
FinVolution initiated with Buy, $9.20 target at China Renaissance » 06:22
09/21/21
09/21
06:22
09/21/21
06:22
FINV

FinVolution Group

$5.55 /

-0.255 (-4.39%)

China Renaissance analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FINV FinVolution Group
$5.55 /

-0.255 (-4.39%)

FINV FinVolution Group
$5.55 /

-0.255 (-4.39%)

04:50 Today China Renaissance
FinVolution Group initiated with a Buy at China Renaissance
08/24/21 Citi
FinVolution Group downgraded to Neutral from Buy at Citi
03/12/21 Citi
FinVolution Group upgraded to Buy from Neutral at Citi
FINV FinVolution Group
$5.55 /

-0.255 (-4.39%)

Initiation
Bechtle initiated with a Buy at UBS » 06:19
09/21/21
09/21
06:19
09/21/21
06:19
BECTY

Bechtle

$14.83 /

+ (+0.00%)

UBS analyst Jad Younes…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BECTY Bechtle
$14.83 /

+ (+0.00%)

08/19/21 Berenberg
Bechtle price target lowered to EUR 58 from EUR 175 at Berenberg
02/09/21 Berenberg
Bechtle price target raised to EUR 175 from EUR 166 at Berenberg
10/28/20 Kepler Cheuvreux
Bechtle upgraded to Buy from Hold at Kepler Cheuvreux
Syndicate
Blue Apron files registration statement for previously announced rights offering » 06:18
09/21/21
09/21
06:18
09/21/21
06:18
APRN

Blue Apron

$4.72 /

-0.32 (-6.35%)

Blue Apron filed a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APRN Blue Apron
$4.72 /

-0.32 (-6.35%)

APRN Blue Apron
$4.72 /

-0.32 (-6.35%)

10/30/20 Canaccord
Blue Apron price target lowered to $14 from $18 at Canaccord
APRN Blue Apron
$4.72 /

-0.32 (-6.35%)

  • 16
    Jun
APRN Blue Apron
$4.72 /

-0.32 (-6.35%)

APRN Blue Apron
$4.72 /

-0.32 (-6.35%)

APRN Blue Apron
$4.72 /

-0.32 (-6.35%)

Hot Stocks
Infosys announces collaboration with ServiceNow » 06:18
09/21/21
09/21
06:18
09/21/21
06:18
INFY

Infosys

$22.77 /

-0.075 (-0.33%)

, NOW

ServiceNow

$648.65 /

-2.845 (-0.44%)

Infosys (INFY) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INFY Infosys
$22.77 /

-0.075 (-0.33%)

NOW ServiceNow
$648.65 /

-2.845 (-0.44%)

INFY Infosys
$22.77 /

-0.075 (-0.33%)

07/15/21 Susquehanna
Infosys price target raised to $22 from $21 at Susquehanna
04/15/21 Susquehanna
Infosys margin reversion due to wage inflation is temporary, says Susquehanna
04/14/21 Stifel
Infosys stock reaction may reflect valuation/sentiment into report, says Stifel
04/14/21 Baird
Infosys price target raised to $18 from $17 at Baird
NOW ServiceNow
$648.65 /

-2.845 (-0.44%)

09/17/21 Barclays
ServiceNow price target raised to $784 from $667 at Barclays
08/19/21 Oppenheimer
ServiceNow assumed with an Outperform at Oppenheimer
07/29/21 BMO Capital
ServiceNow price target raised to $650 from $575 at BMO Capital
07/29/21 KeyBanc
ServiceNow price target raised to $718 from $660 at KeyBanc
INFY Infosys
$22.77 /

-0.075 (-0.33%)

NOW ServiceNow
$648.65 /

-2.845 (-0.44%)

INFY Infosys
$22.77 /

-0.075 (-0.33%)

NOW ServiceNow
$648.65 /

-2.845 (-0.44%)

NOW ServiceNow
$648.65 /

-2.845 (-0.44%)

Initiation
Inhibrx initiated with an Outperform at JMP Securities » 06:18
09/21/21
09/21
06:18
09/21/21
06:18
INBX

Inhibrx

$35.76 /

-1.2 (-3.25%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INBX Inhibrx
$35.76 /

-1.2 (-3.25%)

INBX Inhibrx
$35.76 /

-1.2 (-3.25%)

04/26/21 Credit Suisse
Inhibrx assumed with an Outperform at Credit Suisse
02/03/21 Credit Suisse
Inhibrx price target raised to $44 from $28 at Credit Suisse
INBX Inhibrx
$35.76 /

-1.2 (-3.25%)

Recommendations
Merck faces 'compelling series' of catalysts into 2022, says Barclays » 06:15
09/21/21
09/21
06:15
09/21/21
06:15
MRK

Merck

$71.91 /

+0.21 (+0.29%)

Looking to the end of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$71.91 /

+0.21 (+0.29%)

MRK Merck
$71.91 /

+0.21 (+0.29%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley downgrades Merck to Equal Weight, awaits strategic action
09/07/21 Morgan Stanley
Merck downgraded to Equal Weight from Overweight at Morgan Stanley
MRK Merck
$71.91 /

+0.21 (+0.29%)

MRK Merck
$71.91 /

+0.21 (+0.29%)

MRK Merck
$71.91 /

+0.21 (+0.29%)

MRK Merck
$71.91 /

+0.21 (+0.29%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.